Literature DB >> 23771270

Evaluation of community-acquired sepsis by PIRO system in the emergency department.

Yun-Xia Chen1, Chun-Sheng Li.   

Abstract

The predisposition, infection/insult, response, and organ dysfunction (PIRO) staging system for septic patients allows grouping of heterogeneous patients into homogeneous subgroups. The purposes of this single-center, prospective, observational cohort study were to create a PIRO system for patients with community-acquired sepsis (CAS) presenting to the emergency department (ED) and assess its prognostic and stratification capabilities. Septic patients were enrolled and allocated to derivation (n = 831) or validation (n = 860) cohorts according to their enrollment dates. The derivation cohort was used to identify independent predictors of mortality and create a PIRO system by binary logistic regression analysis, and the prognostic performance of PIRO was investigated in the validation cohort by receiver operator characteristic (ROC) curve. Ten independent predictors of 28-day mortality were identified. The PIRO system combined the components of predisposition (age, chronic obstructive pulmonary disease, hypoalbuminemia), infection (central nervous system infection), response (temperature, procalcitonin), and organ dysfunction (brain natriuretic peptide, troponin I, mean arterial pressure, Glasgow coma scale score). The area under the ROC of PIRO was 0.833 for the derivation cohort and 0.813 for the validation cohort. There was a stepwise increase in 28-day mortality with increasing PIRO score and the differences between the low- (PIRO 0-10), intermediate- (11-20), and high- (>20) risk groups were very significant in both cohorts (p < 0.01). The present study demonstrates that this PIRO system is valuable for prognosis and risk stratification in patients with CAS in the ED.

Entities:  

Mesh:

Year:  2013        PMID: 23771270     DOI: 10.1007/s11739-013-0969-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  19 in total

1.  Performance of illness severity scores to guide disposition of emergency department patients with severe sepsis or septic shock.

Authors:  Bas de Groot; Ernie R J T de Deckere; Roos Flameling; Maro H Sandel; Alice Vis
Journal:  Eur J Emerg Med       Date:  2012-10       Impact factor: 2.799

2.  Proof of principle: the predisposition, infection, response, organ failure sepsis staging system.

Authors:  Michael D Howell; Daniel Talmor; Philipp Schuetz; Sabina Hunziker; Alan E Jones; Nathan I Shapiro
Journal:  Crit Care Med       Date:  2011-02       Impact factor: 7.598

3.  Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED.

Authors:  Ching-Chi Lee; Chung-Hsun Lee; Ming-Che Chuang; Ming-Yuan Hong; Hsiang-Chin Hsu; Wen-Chien Ko
Journal:  Am J Emerg Med       Date:  2011-12-26       Impact factor: 2.469

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

5.  Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.

Authors:  G P Castelli; C Pognani; M Cita; A Stuani; L Sgarbi; R Paladini
Journal:  Minerva Anestesiol       Date:  2006 Jan-Feb       Impact factor: 3.051

6.  Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.

Authors:  A A Dahaba; B Hagara; A Fall; P H Rehak; W F List; H Metzler
Journal:  Br J Anaesth       Date:  2006-07-18       Impact factor: 9.166

7.  Sepsis mortality prediction based on predisposition, infection and response.

Authors:  Rui P Moreno; Barbara Metnitz; Leopold Adler; Anette Hoechtl; Peter Bauer; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2007-12-04       Impact factor: 17.440

8.  Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department.

Authors:  Chien-Chang Lee; Shey-Ying Chen; Chu-Lin Tsai; Shwu-Chong Wu; Wen-Chu Chiang; Jiun-Ling Wang; Hsin-Yun Sun; Shyr-Chyr Chen; Wen-Jone Chen; Po-Ren Hsueh
Journal:  Shock       Date:  2008-03       Impact factor: 3.454

9.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

Authors:  David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

Review 10.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

View more
  4 in total

Review 1.  Hypoalbuminemia as Surrogate and Culprit of Infections.

Authors:  Christian J Wiedermann
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

2.  PIRO concept: staging of sepsis.

Authors:  S Rathour; S Kumar; V Hadda; A Bhalla; N Sharma; S Varma
Journal:  J Postgrad Med       Date:  2015 Oct-Dec       Impact factor: 1.476

3.  Canine parvovirus: a predicting canine model for sepsis.

Authors:  F Alves; S Prata; T Nunes; J Gomes; S Aguiar; F Aires da Silva; L Tavares; V Almeida; S Gil
Journal:  BMC Vet Res       Date:  2020-06-15       Impact factor: 2.741

4.  Prospective international validation of the predisposition, infection, response and organ dysfunction (PIRO) clinical staging system among intensive care and general ward patients.

Authors:  T Cardoso; P P Rodrigues; C Nunes; M Almeida; J Cancela; F Rosa; N Rocha-Pereira; I Ferreira; F Seabra-Pereira; P Vaz; L Carneiro; C Andrade; J Davis; A Marçal; N D Friedman
Journal:  Ann Intensive Care       Date:  2021-12-23       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.